Clinical Trials

NCT03269396 | SUSPENDED | NA
10 participants

Laryngeal Allograft Transplantation

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-22
Start Date:
2023-05-19
Completion:
2028-05-31
Conditions
  • Larynx Stenosis
  • Larynx Disease
  • Laryngectomy
  • Larynx
  • Larynx Fracture
Interventions
  • PROCEDURE
No Results Yet
NCT03065387 | TERMINATED | PHASE1
84 participants

Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-22
Start Date:
2017-10-31
Completion:
2026-04-23
Conditions
  • Advanced Malignant Solid Neoplasm
  • EGFR Gene Amplification
  • EGFR Gene Mutation
  • ERBB2 Gene Amplification
  • ERBB2 Gene Mutation
  • ERBB3 Gene Mutation
  • ERBB4 Gene Mutation
  • KRAS Gene Mutation
  • Metastatic Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
Interventions
  • DRUG
No Results Yet
NCT02974738 | ACTIVE_NOT_RECRUITING | PHASE1
120 participants

A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-22
Start Date:
2016-12-07
Completion:
2018-01-12
Conditions
  • Advanced Solid Tumors
  • Solid Tumor
  • Solid Carcinoma
  • Solid Tumor, Adult
  • ccRCC
  • RCC, Clear Cell Adenocarcinoma
  • RCC
  • Kidney Cancer
  • Clear Cell Renal Cell Carcinoma
  • Renal Cell Carcinoma, Metastatic
  • Renal Cell Carcinoma Recurrent
  • Renal Cell Carcinoma, Clear Cell Adenocarcinoma
  • Glioblastoma
  • Glioblastoma, Adult
  • GBM
  • Glioblastoma Multiforme
Interventions
  • DRUG
No Results Yet
NCT02298959 | ACTIVE_NOT_RECRUITING | PHASE1
59 participants

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-22
Start Date:
2015-04-08
Completion:
2025-05-21
Conditions
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Metastatic Colorectal Carcinoma
  • Metastatic Malignant Solid Neoplasm
  • Metastatic Melanoma
  • Metastatic Ovarian Carcinoma
  • Metastatic Renal Cell Carcinoma
  • Platinum-Resistant Ovarian Carcinoma
  • Recurrent Melanoma
  • Recurrent Renal Cell Carcinoma
  • Refractory Melanoma
  • Refractory Renal Cell Carcinoma
  • Sarcoma
  • Stage IV Colorectal Cancer AJCC v8
  • Stage IV Ovarian Cancer AJCC v8
  • Stage IV Renal Cell Cancer AJCC v8
Interventions
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT02026388 | RECRUITING
2000 participants

Rare Kidney Stone Consortium Biobank

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-22
Start Date:
2013-05-31
Completion:
2030-06-30
Conditions
  • Primary Hyperoxaluria
  • Dent Disease
  • APRT Deficiency
  • Cystinuria
No Results Yet
NCT01479842 | ACTIVE_NOT_RECRUITING | PHASE1
48 participants

Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-22
Start Date:
2014-03-26
Completion:
2026-12-01
Conditions
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • Nodal Marginal Zone B-cell Lymphoma
  • Recurrent Adult Diffuse Large Cell Lymphoma
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Grade 3 Follicular Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Recurrent Marginal Zone Lymphoma
  • Splenic Marginal Zone Lymphoma
  • Waldenstrom Macroglobulinemia
Interventions
  • OTHER
  • DRUG
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page